A Randomised Trial Of Standard Anthracycline-Based Chemotherapy With Fluorouracil, Epirubicin And Cyclophosphamide (FEC) Or Epirubicin And CMF (Epi-CMF) Versus FEC Followed By Sequential Docetaxel As Adjuvant Treatment For Women With Early Breast Cancer.
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Docetaxel (Primary) ; Cyclophosphamide; Cyclophosphamide; Epirubicin; Fluorouracil; Methotrexate
- Indications Early breast cancer
- Focus Adverse reactions; Pharmacogenomic; Registrational; Therapeutic Use
- Acronyms TACT
- 14 Dec 2013 Analysis using parametric cure models presented at the 36th Annual San Antonio Breast Cancer Symposium.
- 08 Dec 2012 Mature survival analysis presented at the 35th Annual San Antonio Breast Cancer Symposium.
- 16 Feb 2010 United Kingdom Clinical Research Network (3800) reports accrual to date changed from 42% to 43%.